Conflict of interest: Nothing to declare.
Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program†
Version of Record online: 17 JAN 2013
Copyright © 2013 Wiley Periodicals, Inc.
Pediatric Blood & Cancer
Volume 60, Issue 5, pages 783–790, May 2013
How to Cite
Keir, S. T., Maris, J. M., Reynolds, C. P., Kang, M. H., Kolb, E. A., Gorlick, R., Lock, R., Carol, H., Morton, C. L., Wu, J., Kurmasheva, R. T., Houghton, P. J. and Smith, M. A. (2013), Initial testing (stage 1) of temozolomide by the pediatric preclinical testing program. Pediatr. Blood Cancer, 60: 783–790. doi: 10.1002/pbc.24368
- Issue online: 14 MAR 2013
- Version of Record online: 17 JAN 2013
- Manuscript Accepted: 17 SEP 2012
- Manuscript Received: 18 FEB 2012
- National Cancer Institute. Grant Numbers: NO1-CM-42216, CA21765, CA108786
Additional Supporting Information may be found in the online version of this article.
|pbc_24368_sm_SuppResDef.doc||77K||Supplemental Response Definitions|
|pbc_24368_sm_SuppTabI.docx||170K||Supplemental Table I.|
|pbc_24368_sm_SuppTabII.docx||136K||Supplemental Table II.|
|pbc_24368_sm_SuppTabIII.docx||153K||Supplemental Table III.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.